LiveRamp CPO awarded 38,961 RSUs in stock grant

Karasick Matthew reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Karasick Matthew reported acquisition or exercise transactions in this Form 4 filing.

LiveRamp Holdings chief product officer Matthew Karasick received a grant of 38,961 restricted stock units of common stock as equity compensation. The RSUs vest over three years, with one-third scheduled to vest on May 22, 2027 and the rest in equal quarterly installments, tied to continued employment. Following this award, he holds 129,440 shares directly.

Insights

Equity compensation analyst

Routine three-year RSU grant to senior executive, no cash trading signal.

Chief product officer Matthew Karasick received 38,961 RSUs of LiveRamp Holdings common stock at no purchase price under the 2005 Equity Compensation Plan. This is standard stock-based compensation, not an open-market transaction.

The RSUs vest over three years, with one-third on May 22, 2027 and the remainder in equal quarterly amounts, contingent on continued employment. This structure encourages long-term retention and aligns part of his pay with future share performance, while not reflecting a buy or sell decision in the market.

Insider Trade Summary

Grant/Award: 38,961 shares

Grant/Award 1 txn

Insider Karasick Matthew

Role CHIEF PRODUCT OFFICER

Type	Security	Shares	Price	Value
Grant/Award	COMMON STOCK, $.10 PAR VALUE	38,961	$0.00	$0.00

Holdings After Transaction: COMMON STOCK, $.10 PAR VALUE — 129,440 shares (Direct)

Footnotes (1)

1. F1. These restricted stock units ("RSUs") are granted pursuant to the registrant's 2005 Equity Compensation Plan. Each RSU represents a contingent right to receive one share of the registrant's common stock. Vesting will take place over three years from the date of grant, with 1/3 of the shares scheduled to vest on May 22, 2027, and the remainder vesting in equal quarterly amounts thereafter on the 22nd day of the applicable month until 100% vested, contingent upon the recipient's continued employment with the registrant.

Key Figures

RSUs granted: 38,961 shares Grant price per RSU: $0.00 per share Shares after transaction: 129,440 shares +2 more

5 metrics

RSUs granted 38,961 shares Restricted stock units granted on May 15, 2026

Grant price per RSU $0.00 per share Equity compensation, no purchase price

Shares after transaction 129,440 shares Total common shares held directly after grant

Initial vesting date May 22, 2027 One-third of RSUs scheduled to vest

Vesting period Three years RSUs vest over three years with quarterly installments

Key Terms

restricted stock units ("RSUs"), 2005 Equity Compensation Plan, vesting, contingent right, +1 more

5 terms

restricted stock units ("RSUs") financial

"These restricted stock units ("RSUs") are granted pursuant to the registrant's 2005 Equity Compensation Plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2005 Equity Compensation Plan financial

"These restricted stock units ("RSUs") are granted pursuant to the registrant's 2005 Equity Compensation Plan."

vesting financial

"Vesting will take place over three years from the date of grant, with 1/3 of the shares scheduled to vest on May 22, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

contingent right financial

"Each RSU represents a contingent right to receive one share of the registrant's common stock."

continued employment financial

"until 100% vested, contingent upon the recipient's continued employment with the registrant."

Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LiveRamp (RAMP) executive Matthew Karasick report on this Form 4?

Matthew Karasick reported receiving 38,961 restricted stock units of LiveRamp common stock as an equity award. The grant is part of the company’s 2005 Equity Compensation Plan and does not involve any open-market purchase or sale of existing shares.

How many LiveRamp (RAMP) RSUs were granted to Matthew Karasick and at what price?

He was granted 38,961 restricted stock units with a stated price of $0.00 per share, reflecting a compensation award rather than a market trade. Each unit represents a right to receive one share of LiveRamp common stock when vesting conditions are met.

What is the vesting schedule for Matthew Karasick’s LiveRamp (RAMP) RSU award?

The RSUs vest over three years, with one-third scheduled to vest on May 22, 2027. The remaining two-thirds vest in equal quarterly installments on the 22nd of applicable months, contingent on his continued employment with LiveRamp.

How many LiveRamp (RAMP) shares does Matthew Karasick hold after this RSU grant?

After the reported grant, Matthew Karasick holds 129,440 shares of LiveRamp common stock directly. This figure reflects his position following the RSU award and helps investors gauge the scale of the equity compensation relative to his overall holdings.

Does this LiveRamp (RAMP) Form 4 indicate insider buying or selling in the market?

The filing reflects an equity grant, not market buying or selling. Matthew Karasick received 38,961 RSUs as compensation under a company plan, so no open-market purchase or sale price is involved, and there is no immediate cash transaction with public investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 06:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Karasick Matthew

(Last) (First) (Middle)

LIVERAMP HOLDINGS, INC.

225 BUSH STREET, 17TH FLOOR

(Street)

SAN FRANCISCO CALIFORNIA 94104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LiveRamp Holdings, Inc. [ RAMP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF PRODUCT OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK, $.10 PAR VALUE	05/15/2026		A		38,961(1)	A	$0	129,440	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These restricted stock units ("RSUs") are granted pursuant to the registrant's 2005 Equity Compensation Plan. Each RSU represents a contingent right to receive one share of the registrant's common stock. Vesting will take place over three years from the date of grant, with 1/3 of the shares scheduled to vest on May 22, 2027, and the remainder vesting in equal quarterly amounts thereafter on the 22nd day of the applicable month until 100% vested, contingent upon the recipient's continued employment with the registrant.

	/s/ BY: JERRY C. JONES, ATTORNEY-IN-FACT FOR: MATTHEW KARASICK	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)